Translations:Niacin/2/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
14,895 edits
Importing a new version from external source
Tags: Mobile edit Mobile web edit
 
(No difference)

Latest revision as of 09:42, 20 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Niacin)
| Beilstein = 109591
| Gmelin = 3340
| 3DMet = B00073
| SMILES = OC(=O)c1cccnc1
| StdInChI = 1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| InChI = 1/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)
| StdInChIKey = PVNIIMVLHYAWGP-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| InChIKey = PVNIIMVLHYAWGP-UHFFFAOYAA
}}
|Section2={{Chembox Properties
| C=6 | H=5 | N=1 | O=2
| Appearance = White, translucent crystals
| MeltingPtK = 510
| Density = 1.473 g cm<sup>−3</sup>
| Solubility = 18 g L<sup>−1</sup>
| LogP = 0.219
| pKa = 2.0, 4.85
| IsoelectricPt = 4.75
| RefractIndex = 1.4936
| Dipole = 0.1271305813 D
}}
|Section5={{Chembox Thermochemistry
| DeltaHf = −344.9 kJ mol<sup>−1</sup>
| DeltaHc = −2.73083 MJ mol<sup>−1</sup>
}}
|Section6={{Chembox Pharmacology
| ATCCode_prefix = C04
| ATCCode_suffix = AC01
| ATC_Supplemental = {{ATC|C10|BA01}} {{ATC|C10|AD02}} {{ATC|C10|AD52}}
| Licence_EU=yes
| INN_EMA=Nicotinic acid
| AdminRoutes = Intramuscular, by mouth
| HalfLife = 20–45 min
}}
|Section7={{Chembox Hazards
| GHSPictograms = {{GHS07}}
| GHSSignalWord = Warning
| HPhrases = {{H-phrases|319}}
| PPhrases = {{P-phrases|264|280|305+351+338|337+313|501}}
| NFPA-H = 1
| NFPA-F = 1
| NFPA-R = 0
| FlashPtC = 193
| AutoignitionPtC = 365
}}
}}
{{Infobox drug
| container_only = yes
| drug_name        = 
| INN              = Nicotinic acid
| type              = <!-- empty -->
| image            = 
| width            = 
| alt              = 
| caption          = 
| USAN              = 
| INN_EMA          = Nicotinic acid

| Beilstein = 109591 | Gmelin = 3340 | 3DMet = B00073 | SMILES = OC(=O)c1cccnc1 | StdInChI = 1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9) | StdInChI_Ref =  checkY | InChI = 1/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9) | StdInChIKey = PVNIIMVLHYAWGP-UHFFFAOYSA-N | StdInChIKey_Ref =  checkY | InChIKey = PVNIIMVLHYAWGP-UHFFFAOYAA }} |Section2=! colspan=2 style="background: #f8eaba; text-align: center;" |Properties

|-

|

Chemical formula

| C6H5NO2

|- | Molar mass

| 123.111 g·mol−1

|- | Appearance | White, translucent crystals |-

| Density | 1.473 g cm−3 |- | Melting point | 237 °C; 458 °F; 510 K

|-


|

Solubility in water

| 18 g L−1 |-





| log P | 0.219 |-


| Acidity (pKa) | 2.0, 4.85 |-


| Isoelectric point | 4.75 |-





|

Refractive index (nD)

| 1.4936 |-


|

Dipole moment

| 0.1271305813 D |- |Section5=! colspan=2 style="background: #f8eaba; text-align: center;" |Thermochemistry

|-


|

Std enthalpy of
formation (ΔfH⦵298)

| −344.9 kJ mol−1 |-

|

Std enthalpy of
combustion (ΔcH⦵298)

| −2.73083 MJ mol−1 |- |Section6=! colspan=2 style="background: #f8eaba; text-align: center;" |Pharmacology

|-

|

ATC code

| C04AC01 (WHO) C10BA01 (WHO) C10AD02 (WHO) C10AD52 (WHO) |-

| License data

|

|-


|

Routes of
administration

| Intramuscular, by mouth |- | colspan=2 style="text-align:left; background-color:#eaeaea;" | Pharmacokinetics: |- |- style="background:#f1f1f1;"

| style="padding-left:1em;" |

Biological half-life

| 20–45 min

|- |- |Section7=! colspan=2 style="background: #f8eaba; text-align: center;" |Hazards

|-

| colspan=2 style="text-align:left; background-color:#eaeaea;" | GHS labelling: |-

|- style="background:#f1f1f1;"

| style="padding-left:1em;" |

Pictograms

| GHS07: Exclamation mark

|-

|- style="background:#f1f1f1;"

| style="padding-left:1em;" |

Signal word

| Warning

|-

|- style="background:#f1f1f1;"

| style="padding-left:1em;" |

Hazard statements

| H319

|-

|- style="background:#f1f1f1;"

| style="padding-left:1em;" |

Precautionary statements

| P264, P280, P305+P351+P338, P337+P313, P501

|- | NFPA 704 (fire diamond)

|

NFPA 704 four-colored diamondHealth 1: Exposure would cause irritation but only minor residual injury. E.g. turpentineFlammability 1: Must be pre-heated before ignition can occur. Flash point over 93 °C (200 °F). E.g. canola oilInstability 0: Normally stable, even under fire exposure conditions, and is not reactive with water. E.g. liquid nitrogenSpecial hazards (white): no code
1
1
0

|- | Flash point | 193 °C (379 °F; 466 K)

|-

|

Autoignition
temperature

| 365 °C (689 °F; 638 K)

|- }} {{Infobox drug | container_only = yes | drug_name = | INN = Nicotinic acid | type = | image = | width = | alt = | caption = | USAN = | INN_EMA = Nicotinic acid

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Niacin/2/en&oldid=117702"